Day Two
Explore the Agenda
7:30 am Registration & Light Breakfast
8:35 am Chair’s Opening Remarks & Recap of Day One
Simplifying Scientific Complexity of Advanced Therapies to Draft Defensible, Broad Claims
8:45 am Fireside Chat: Confronting Enablement Risks to Strengthen Drafting Strategy
Synopsis
- Hear how recent decisions (e.g. Amgen v. Sanofi) are impacting strategy
- Discuss when to aim for breadth vs. depth in claim language
- Understand how to avoid overreaching without under protecting
9:15 am Presentation: Drafting Patent Strategies for Genetically Modified vs. Unmodified Cell Therapies
Synopsis
- Compare how patent strategies differ for genetically modified versus unmodified allogeneic cell therapies under U.S. law
- Explore key challenges in claiming unmodified cells, including novelty, inventiveness, and eligibility
- Learn practical drafting approaches to protect compositions, methods, and therapeutic use across both therapy types
9:45 am Panel Discussion: Aligning Legal and Scientific Teams to Unlock Stronger Patent Claims
Synopsis
- Learn practical approaches to coaching scientists for clearer, claim-ready disclosures
- Explore strategies for drafting patent claims that address the unique scientific and legal challenges across advanced therapy modalities
- Hear real-world stories where misalignment created challenges and how they were overcome
10:30 am Morning Break & Networking
Balancing Trade Secrets and Patents to Strengthen Protection & Reinforce Competitive Advantage
11:00 am Presentation: Choosing Secrecy Strategically to Strengthen Protection Beyond Patents
Synopsis
- Define what makes strong, enforceable trade secrets in advanced therapies
- Understand legal thresholds and organizational processes for secrecy
- Learn how secrecy complements formal IP in competitive settings
11:30 am Roundtable Discussion: Assessing IP Protection Scenarios to Decide What Should Be Kept Secret
Synopsis
- Debate anonymized case examples to weigh patenting vs. trade secrecy
- Evaluate risks of disclosure vs. strength of trade secret protections
- Crowdsource policies for hybrid IP strategies in complex pipelines
12:00 pm Networking Lunch
Clarifying Freedom to Operate to Accelerate Launch, Strengthen Licensing & Apply AI Strategically
1:00 pm Fireside Chat: Building Smart FTO Strategies to Support Commercial Launch & Avoid Legal Delays
Synopsis
- Map the steps from patent landscaping to formal FTO opinion
- How proactive FTO can accelerate licensing, investment, and launch timelines
- Unpacking strategies to manage third-party IP conflicts and avoid costly delays
1:30 pm Panel Discussion: Licensing IP Assets to Unlock Revenue & Partnership Value
Synopsis
- Explore licensing approaches from early-stage out-licensing to mature monetization
- Discuss how to position IP for pharma partnerships or M&A
- Learn negotiation best practices that preserve long-term flexibility
2:15 pm Afternoon Break & Networking
Strengthening Enforcement Strategy to Reduce Litigation Risk & Safeguard Market Access
2:45 pm Presentation: Defending High-Value Portfolios to Minimize Litigation Risk & Protect Market Access
Synopsis
- Analyze litigation trends in CRISPR, LNP, and gene editing patent battles
- Understand how enablement rulings and biosimilar threats impact advanced therapy IP
- Explore portfolio tactics that strengthen positioning in disputes and due diligence
3:15 pm Audience Discussion: Preparing IP Portfolios to Withstand Litigation, Transactions & Competitive Scrutiny
Synopsis
- Exploring practical steps to strengthen portfolios ahead of due diligence or licensing negotiations
- Identifying weaknesses in internal IP governance that can undermine enforceability or deal value
- Sharing strategies to align IP documentation, ownership, and clarity for investor and partner readiness